Alzheimer’s Disease: A History of Progress and Challenges Toward Discovery of a Cure
DOI:
https://doi.org/10.47611/jsrhs.v13i4.8047Keywords:
Alzheimer's Disease, Neurodegenerative Diseases, Gene Therapy, Genetics Testing, Human Genome ProjectAbstract
Neurodegenerative Diseases like Alzheimer’s Disease (AD) have puzzled researchers and scientists for decades. Through the years, though, advancements in technology and our understanding of biology itself have brought us closer to the end goal of a cure. This review takes a deep dive through the last 30 years of progress and challenges faced by those working on diagnosing and curing this bleak disease, from the initiation of the Human Genome Project to the emergence of genetics testing companies to some of the most recent, promising studies and clinical trials. While researchers and scientists have achieved several important milestones and developed many crucial technologies, the process of diagnosing and treating Alzheimer’s has not come without a long history of legal, ethical, and discriminatory issues, which will be discussed. The discovery of a cure, though, ultimately dismisses these issues, and as of right now, gene therapy seems to be the most promising path to that cure.
Downloads
References or Bibliography
Arab, L., & Sabbagh, M. N. (2010). Are certain lifestyle habits associated with lower Alzheimer's disease risk?. Journal of Alzheimer's disease: JAD, 20(3), 785–794. https://doi.org/10.3233/JAD-2010-091573
Awada, Adnan, (2015). Early and late-onset Alzheimer’s disease: What are the differences? Journal of neurosciences in rural practice. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481819/
Bombard, Y., Veenstra, G., Friedman, J. M., Creighton, S., Currie, L., Paulsen, J. S., Bottorff, J. L., Hayden, M. R., & Canadian Respond-HD Collaborative Research Group (2009). Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey. BMJ (Clinical research ed.), 338, b2175. https://doi.org/10.1136/bmj.b2175
Cara, E. (2023, April 14). The Human Genome Project Turns 20: Here’s how it altered the world. MIT Department of Biology. https://biology.mit.edu/the-human-genome-project-turns-20-heres-how-it-altered-the-world/
Collins, F. S., Patrinos, A., Jordan, E., Chakravarti, A., Gesteland, R., & Walters, L. (1998). New goals for the U.S. Human Genome Project: 1998-2003. Science (New York, N.Y.), 282(5389), 682–689. https://doi.org/10.1126/science.282.5389.682
DNA Reports List. 23andMe.com. (2024) https://www.23andme.com/dna-reports-list/
Dunham, I., Hunt, A., Collins, J., et al. (1999) The DNA sequence of human chromosome 22. Nature 402, 489–495 https://doi.org/10.1038/990031
Fagerlin, A., Zikmund-Fisher, B. J., & Ubel, P. A. (2011). Helping patients decide: ten steps to better risk communication. Journal of the National Cancer Institute, 103(19), 1436–1443. https://doi.org/10.1093/jnci/djr318
Gannett, Lisa, (2023) The Human Genome Project, The Stanford Encyclopedia of Philosophy (Fall 2023 Edition), Edward N. Zalta & Uri Nodelman (eds.) https://plato.stanford.edu/archives/fall2023/entries/human-genome/
Gene Therapy. Pennmedicine.org. (2024). https://www.pennmedicine.org/research-at-penn/gene-therapy
Hayden, E. C. (2017, October 12). The rise and fall and rise again of 23andMe. Nature 550, 174-177. https://doi.org/10.1038/550174a
Human genome project fact sheet. Genome.gov. (2024, June 13). https://www.genome.gov/about-genomics/educational-resources/fact-sheets/human-genome-proj
Ect
Human genome project timeline. Genome.gov. (2022, July 5). https://www.genome.gov/human-genome-project/timeline
Huntington’s Disease Society of America, (2016) Genetic Testing Protocol for Huntington’s Disease. http://hdsa.org/wp-content/uploads/2015/02/HDSA-Gen-Testing-Protocol-for-HD.pdf
InformedHealth.org [Internet]. (2006) In brief: What does genetic testing involve? Cologne, Germany, Institute for Quality and Efficiency in Health Care (IQWiG) https://www.ncbi.nlm.nih.gov/books/NBK367582/
Institute of Medicine (US) Committee on Health Literacy, Nielsen-Bohlman, L., Panzer, A. M., & Kindig, D. A. (Eds.). (2004). Health Literacy: A Prescription to End Confusion. National Academies Press (US). https://pubmed.ncbi.nlm.nih.gov/25009856/
Levy, B. (2023, December 12). Gene therapy protects neurons from Alzheimer’s disease. National Institutes of Health. https://irp.nih.gov/blog/post/2023/12/gene-therapy-protects-neurons-from-alzheimers-disease
McGuire, A. L., & Burke, W. (2008). An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. JAMA, 300(22), 2669–2671. https://doi.org/10.1001/jama.2008.803
National Health Service. (2024, January 26). Clinical trials show promise for first ‘gene silencing’ treatment for Alzheimer’s disease. NHS England. https://www.genomicseducation.hee.nhs.uk/blog/clinical-trials-show-promise-for-first-gene-silencing-treatment-for-alzheimers-disease/
Quaid K. A. (2017). Genetic testing for Huntington's disease. Handbook of Clinical Neurology, 144, 113–126. https://doi.org/10.1016/B978-0-12-801893-4.00010-9
Ramos, E., & Weissman, S. M. (2018). The dawn of consumer-directed testing. American journal of medical genetics. Part C, Seminars in medical genetics, 178(1), 89–97. https://doi.org/10.1002/ajmg.c.31603
Roberts, J. S., Gornick, M. C., Carere, D. A., Uhlmann, W. R., Ruffin, M. T., & Green, R. C. (2017). Direct-to-Consumer Genetic Testing: User Motivations, Decision Making, and Perceived Utility of Results. Public health genomics, 20(1), 36–45. https://doi.org/10.1159/000455006
Roberts, J. S., Patterson, A. K., & Uhlmann, W. R. (2020). Genetic testing for neurodegenerative diseases: Ethical and health communication challenges. Neurobiology of disease, 141, 104871. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311284/
Sudhakar, V., & Richardson, R. M. (2019). Gene Therapy for Neurodegenerative Diseases. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, 16(1), 166–175. https://doi.org/10.1007/s13311-018-00694-0
Taylor, D. H., Jr, Cook-Deegan, R. M., Hiraki, S., Roberts, J. S., Blazer, D. G., & Green, R. C. (2010). Genetic testing for Alzheimer's and long-term care insurance. Health affairs (Project Hope), 29(1), 102–108. https://doi.org/10.1377/hlthaff.2009.0525
Vernarelli, J. A., Roberts, J. S., Hiraki, S., Chen, C. A., Cupples, L. A., & Green, R. C. (2010). Effect of Alzheimer disease genetic risk disclosure on dietary supplement use. The American journal of clinical nutrition, 91(5), 1402–1407. https://doi.org/10.3945/ajcn.2009.28981
Watson, James D. 1990. “The Human Genome Project: Past, Present, and Future.” Science, 248 (6 Apr): 44–49.
Xiao, L., Yang, X., Sharma, V. K., Abebe, D., & Loh, Y. P. (2023). Hippocampal delivery of neurotrophic factor-α1/carboxypeptidase E gene prevents neurodegeneration, amyloidosis, memory loss in Alzheimer's Disease male mice. Molecular psychiatry, 28(8), 3332–3342. https://doi.org/10.1038/s41380-023-02135-7
Zhou, X., Chen, Y., Ip, F.C.F., et al. (2023) Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction. Communications Medicine 3, 49 (2023). https://doi.org/10.1038/s43856-023-00269-x
Zhu, Tian, Carvalho, Tito, "The Human Genome Project (1990-2003)". Embryo Project Encyclopedia (2014-05-06). ISSN: 1940-5030 https://hdl.handle.net/10776/7829
Published
How to Cite
Issue
Section
Copyright (c) 2024 Derek Qi; David Zierler
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
